Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | |||||||||
|
follistatin like 3 | 0.695 | 0.423 | 0.69 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
adeno-associated virus integration site 1 | 0.595 | 0.731 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | |||||||||
|
deleted in malignant brain tumors 1 | 0.533 | 0.654 | 4.5E-63 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
nuclear receptor subfamily 0 group B member 1 | 0.494 | 0.808 | 0.97 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
rhabdomyosarcoma 2 associated transcript | 0.769 | 0.385 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | |||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
tetraspanin 15 | 0.780 | 0.346 | 8.0E-03 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
myosin regulatory light chain interacting protein | 0.582 | 0.692 | 0.18 |
|
group | 0.010 | None | < 0.001 | 1 | 1 | 2015 | 2015 | ||||||||
|
inosine triphosphatase | 0.604 | 0.500 | 1.0E-07 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
galectin 2 | 0.700 | 0.385 | 2.0E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ghrelin and obestatin prepropeptide | 0.517 | 0.769 | 1.4E-11 |
|
group | 0.010 | None | < 0.001 | 1 | 1 | 2003 | 2003 | ||||||||
|
peripheral myelin protein 22 | 0.471 | 0.885 | 0.91 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
centromere protein J | 0.546 | 0.846 | 2.1E-27 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
solute carrier family 44 member 2 | 0.743 | 0.462 | 1.2E-04 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
prostaglandin E receptor 2 | 0.597 | 0.731 | 7.5E-03 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
Bardet-Biedl syndrome 4 | 0.647 | 0.615 | 1.5E-16 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
ribosomal protein S20 | 0.610 | 0.692 | 2.1E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
solute carrier family 20 member 2 | 0.638 | 0.577 | 0.97 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
thromboxane A synthase 1 | 0.619 | 0.615 | 1.4E-20 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
thrombospondin 2 | 0.526 | 0.769 | 0.56 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 |